<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04142411</url>
  </required_header>
  <id_info>
    <org_study_id>AssiutUKAboshaera01</org_study_id>
    <nct_id>NCT04142411</nct_id>
  </id_info>
  <brief_title>Combined Effect of Insulin and Sodium Hyaluronate Injection Guided by Ultrasound in Carpal Tunnel Syndrome</brief_title>
  <acronym>PIT</acronym>
  <official_title>Combined Effect of Insulin and Sodium Hyaluronate Injection Guided by Ultrasound in Carpal Tunnel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with
      involving compression of the median nerve in the carpal tunnel. The technique of perineural
      injection therapy (PIT) is now commonly used for peeling the nerve from surrounding soft
      tissue (called nerve hydrodissection), which may help to reduce neuro-inflammation, ischemic
      damage and allow impulse transmission.

      The objective of this study is to evaluate the efficacy of ultrasound guided insulin plus
      Sodium Hyaluronate injection in reducing symptoms caused by carpal tunnel syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized clinical trial, 90 patients with both a clinical and electromyographic
      diagnosis of mild to moderate carpal tunnel syndrome will be recruited from Assiut University
      Hospital (AUH). After obtaining written informed consent, patients will be randomized into
      three groups. Group A, patients will receive ultrasound-guided PIT with 10 IU of crystalline
      insulin; Group B, patients will receive ultrasound-guided PIT with 20 mg of Sodium
      Hyaluronate; Group C, patients will receive ultrasound-guided PIT with 10 IU of crystalline
      insulin and 20 mg of Sodium Hyaluronate. The primary outcome will be the Boston Carpal Tunnel
      Syndrome Questionnaire - Symptom Severity Scale at baseline, 1 month and 3 months post
      injection. All participants, investigator, outcomes assessor will be blinded (Triple blind)
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2019</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Boston Carpal Tunnel Syndrome Questionnaire - Symptom Severity Scale</measure>
    <time_frame>Baseline, 1 month, 3 months</time_frame>
    <description>Boston carpal tunnel syndrome questionnaire - SSS is patient-based questionnaire for measurement of CTS severity which include11 questions to evaluate the symptom severity. Each question ranges from 1 to 5 with a higher score indicating a higher degree of disability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Boston Carpal Tunnel Syndrome Questionnaire - Functional Status Scale</measure>
    <time_frame>Baseline, 1 month, 3 months</time_frame>
    <description>Boston carpal tunnel syndrome questionnaire - FSS is patient-based questionnaire for measurement of CTS functional disability which include 8 items to evaluate the functional status scale (FSS). Each item ranges from 1 to 5 with a higher score indicating a higher degree of disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropathic pain Visual Analog Scale (VAS)</measure>
    <time_frame>Baseline, 1 month, 3 months</time_frame>
    <description>Digital pain severity or paresthesia/dysthesia was evaluated using visual analog scale (VAS). Pain score scale ranged from 0 to 10, with 10 indicating the most severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>U/S measured medial nerve mean CSA</measure>
    <time_frame>Baseline, 1 month, 3 months</time_frame>
    <description>Ultrasound measured medial nerve mean cross sectional area at the Pisiform bone level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>U/S measured medial nerve CSA difference</measure>
    <time_frame>Baseline, 1 month, 3 months</time_frame>
    <description>Ultrasound measured medial nerve cross sectional area difference between pronator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>U/S hyper-vascularization of medial nerve percentage</measure>
    <time_frame>Baseline, 1 month, 3 months</time_frame>
    <description>Percentage of Ultrasound hyper-vascularization of medial nerve in carpal tunnel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory nerve conduction velocity of the median nerve</measure>
    <time_frame>Baseline, 1 month, 3 months</time_frame>
    <description>Antidromic sensory nerve conduction velocity of the median nerve</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction (Likert scale)</measure>
    <time_frame>1month, 3 months</time_frame>
    <description>Likert scale with the grade 1 means that the patient's satisfaction was 30%, grade 2, the patient's satisfaction was 30-50%, grade 3, the satisfaction was 50-80%, and grade 4 was 80%, Grades 3 and 4 were defined as &quot;overall satisfied&quot;</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>Insulin and Sodium Hyaluronate Ultrasound guided injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive Ultrasound guided injection of 10 IU of crystalline insulin and 20 mg of Sodium Hyaluronate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin Ultrasound guided injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive Ultrasound guided injection of 10 IU of crystalline insulin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium Hyaluronate Ultrasound guided injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive Ultrasound guided injection of 20 mg of Sodium Hyaluronate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <description>Ultrasound guided perineural injection therapy (PIT)</description>
    <arm_group_label>Insulin Ultrasound guided injection</arm_group_label>
    <arm_group_label>Insulin and Sodium Hyaluronate Ultrasound guided injection</arm_group_label>
    <other_name>Crystalline Insulin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Hyaluronate</intervention_name>
    <description>Ultrasound guided perineural injection therapy (PIT)</description>
    <arm_group_label>Insulin and Sodium Hyaluronate Ultrasound guided injection</arm_group_label>
    <arm_group_label>Sodium Hyaluronate Ultrasound guided injection</arm_group_label>
    <other_name>Hyalgan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Philips Neuromuscular Ultrasound</description>
    <arm_group_label>Insulin Ultrasound guided injection</arm_group_label>
    <arm_group_label>Insulin and Sodium Hyaluronate Ultrasound guided injection</arm_group_label>
    <arm_group_label>Sodium Hyaluronate Ultrasound guided injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 to 65

          -  Understanding written and spoken Arabic consent

          -  Diagnostic of carpal tunnel syndrome: Classic of probable based on the Katz Hand
             Diagram and mild to moderate based on the electrodiagnosis studies

        Exclusion Criteria:

          -  Diseases known to cause carpal tunnel syndrome: Diabetes mellitus, hypothyroidism,
             connective tissue disease, rheumatic disease and moderate or severe chronic renal
             impairment

          -  Secondary diagnosis based on the ultrasound: arthrosynovial cyst, flexor
             tenosynovitis, ganglion

          -  Constant symptoms in medial nerve area

          -  Thenar eminence atrophy

          -  Cervical radiculopathy

          -  Brachial plexopathy

          -  Thoracic outlet syndrome

          -  Polyneuropathy

          -  Pregnancy

          -  Cognitive disorder

          -  Anticoagulant therapy

          -  Carpal tunnel injection in the last 6 months

          -  Ancient ipsilateral wrist fracture

          -  Ancient ipsilateral wrist surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaled O Aboshaera, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khaled O Aboshaera, MD</last_name>
    <phone>01003012229</phone>
    <email>khalednao26@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medicine</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Khaled O Aboshaera, MD</last_name>
      <phone>01003012229</phone>
      <email>khalednao26@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Smith J, Wisniewski SJ, Finnoff JT, Payne JM. Sonographically guided carpal tunnel injections: the ulnar approach. J Ultrasound Med. 2008 Oct;27(10):1485-90. Review.</citation>
    <PMID>18809959</PMID>
  </reference>
  <reference>
    <citation>Kamel SR, Sadek HA, Hamed A, Sayed OA, Mahmud MH, Mohamed FA, El Sagher GM, Aly LH. Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients. Clin Rheumatol. 2019 Oct;38(10):2933-2940. doi: 10.1007/s10067-019-04638-7. Epub 2019 Jun 17.</citation>
    <PMID>31209710</PMID>
  </reference>
  <reference>
    <citation>Apel PJ, Ma J, Callahan M, Northam CN, Alton TB, Sonntag WE, Li Z. Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats. Muscle Nerve. 2010 Mar;41(3):335-41. doi: 10.1002/mus.21485.</citation>
    <PMID>19802878</PMID>
  </reference>
  <reference>
    <citation>Ten Broek RPG, Stommel MWJ, Strik C, van Laarhoven CJHM, Keus F, van Goor H. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet. 2014 Jan 4;383(9911):48-59. doi: 10.1016/S0140-6736(13)61687-6. Epub 2013 Sep 27. Review.</citation>
    <PMID>24075279</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>October 25, 2019</last_update_submitted>
  <last_update_submitted_qc>October 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Khaled Osama Aboshaera</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

